EX-32.1 9 silk-20221231xex32_1.htm EX-32.1 Exhibit 32.1

Exhibit 32.1

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report of Silk Road Medical, Inc. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:



1.    The Report, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and



2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





 

 



 

/s/ Erica J. Rogers



 

Erica J. Rogers



 

President, Chief Executive Officer and Director



 

(Principal Executive Officer)



 

 



 

Date: February 28,  2023







 

 



 

/s/ Lucas W. Buchanan



 

Lucas W. Buchanan



 

Chief Financial Officer and Chief Operating Officer



 

(Principal Financial and Accounting Officer)



 

 



 

Date: February 28,  2023